人乳头瘤病毒疫苗研究历程

被引：8

作者：

李启明

张靖

机构：

[1] 北京生物制品研究所

来源：

中华微生物学和免疫学杂志 | 2012年 / 12期

关键词：

D O I：

暂无

中图分类号：

R737 [泌尿生殖器肿瘤];

学科分类号：

100214 ;

摘要：

<正>早在1907年,Ciuffo就曾报道,分离自人疣体的细胞超滤物可引起不同个体间皮肤疣的传播。直到1933年,Shop首先分离和鉴定了美洲兔乳头瘤病毒,随后,研究人员不断从人或动物体中分离出大量不同型别的乳头瘤病毒

引用

页码：1074 / 1079

共 16 条

[1] Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis [J].

Malagon, Talia ;

Drolet, Melanie ;

Boily, Marie-Claude ;

Franco, Eduardo L. ;

Jit, Mark ;

Brisson, Jacques ;

Brisson, Marc .

LANCET INFECTIOUS DISEASES, 2012, 12 (10) :781-789

[2]

Global Burden of Human Papillomavirus and Related Diseases.[J].David Forman;Catherine de Martel;Charles J. Lacey;Isabelle Soerjomataram;Joannie Lortet-Tieulent;Laia Bruni;Jerome Vignat;Jacques Ferlay;Freddie Bray;Martyn Plummer;Silvia Franceschi.Vaccine.2012,

[3]

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines.[J].John T. Schiller;Xavier Castellsagué;Suzanne M. Garland.Vaccine.2012,

[4] Laboratory and clinical aspects of human papillomavirus testing [J].

Chan, Paul K. S. ;

Alejandra Picconi, Maria ;

Cheung, Tak Hong ;

Giovannelli, Lucia ;

Park, Jong Sup .

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2012, 49 (04) :117-136

[5] Assessment of clinical and analytical performance characteristics of an HPV genotyping test [J].

Schutzbank, Ted E. ;

Ginocchio, Christine C. .

DIAGNOSTIC CYTOPATHOLOGY, 2012, 40 (04) :367-373

[6]

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine.[J].Cecilia M. Roteli-Martins;Paulo Naud;Paola De Borba;Julio C. Teixeira;Newton S. De Carvalho;Toufik Zahaf;Nervo Sanchez;Brecht Geeraerts;Dominique Descamps.Human Vaccines & Immunotherapeutics.2012, 3

[7] The known unknowns of HPV natural history [J].

Gravitt, Patti E. .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (12) :4593-4599

[8]

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years.[J].Mark H. Einstein;Mira Baron;Myron J Levin;Archana Chatterjee;Bradley Fox;Sofia Scholar;Jeffrey Rosen;Nahida Chakhtoura;Marie Lebacq;Robbert van der Most;Philippe Moris;Sandra L. Giannini;Anne Schuind;Sanjoy Kumar Datta;Dominique Descamps.Human Vaccines.2011, 12

[9] Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection [J].

Jagu, Subhashini ;

Kwak, Kihyuck ;

Garcea, Robert L. ;

Roden, Richard B. S. .

VACCINE, 2010, 28 (28) :4478-4486

[10]

Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma.[J].Giuseppina Cantarella;Matthias Liniger;Armando Zuniga;John T. Schiller;Martin Billeter;Hussein Y. Naim;Reinhard Glueck.Vaccine.2009, 25

← 1 2 →